Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Silvercorp Metals, Inc. (“Silvercorp” or the “Company”) (NYSE: SVM), concerning whether the company and certain of its officers and directors have violated federal securities laws.

On September 1, 2011, the Company was forwarded a copy of an anonymous letter dated August 29, 2011, addressed to the Ontario Securities Commission, the Company’s auditors, and various media outlets alleging a “Potential $1.3 Billion Accounting Fraud at Silvercorp. The letter also alleges that Silvercorp reported a profit in 2010 in a Securities and Exchange Commission Filing, while also reporting a loss to Chinese regulators. The anonymous author also acknowledged he had taken a short position in the Company. On Friday, September 9, 2011, The British Columbia Securities Commission confirmed it was investigating this anonymous allegation against Silvercorp. On this news, shares of Silvercorp plummeted $1.54 or about 20% to close at $6.30 on Tuesday, September 13, 2011.

If you are aware of any facts relating to this investigation, or purchased shares of Silvercorp, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email Those who inquire by e-mail are encouraged to include their mailing address and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate work, private securities offerings, and securities arbitration.

Copyright Business Wire 2010

If you liked this article you might like

Interesting SVM Call Options For September 18th

5 Stocks Under $10 Set to Soar

4 Stocks Under $10 in Breakout Territory

6 Stocks Under $10 Triggering Major Breakouts

5 Toxic Stocks You Should Sell in April